HURA
Price:
$2.32
Market Cap:
$147.74M
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Industry
Biotechnology
IPO Date
2013-02-22
Stock Exchange
NASDAQ
Ticker
HURA
According to TuHURA Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -153.99%. This represents a change of 294.49% compared to the average of -39.03% of the last 4 quarters.
The mean historical ROE of TuHURA Biosciences, Inc. over the last ten years is -141.59%. The current -153.99% ROE has changed 8.75% with respect to the historical average. Over the past ten years (40 quarters), HURA's ROE was at its highest in in the December 2023 quarter at 623.78%. The ROE was at its lowest in in the June 2020 quarter at -1452.43%.
Average
-141.59%
Median
-146.09%
Minimum
-3469.96%
Maximum
3.03%
Discovering the peaks and valleys of TuHURA Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 748.29%
Maximum Annual ROE = 3.03%
Minimum Annual Increase = -937.21%
Minimum Annual ROE = -3469.96%
| Year | ROE | Change |
|---|---|---|
| 2025 | -143.61% | -3.34% |
| 2024 | -148.57% | -127.83% |
| 2023 | 533.76% | -548.32% |
| 2022 | -119.06% | -103.93% |
| 2021 | 3.03% | -937.21% |
| 2021 | -361.95% | -89.57% |
| 2020 | -3469.96% | 748.29% |
| 2019 | -409.05% | 99.61% |
| 2018 | -204.93% | 66.81% |
| 2017 | -122.85% | -32.67% |
The current ROE of TuHURA Biosciences, Inc. (HURA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
80.53%
5-year avg
630.56%
10-year avg
-141.59%
TuHURA Biosciences, Inc.’s ROE is greater than Seer, Inc. (-26.58%), greater than VistaGen Therapeutics, Inc. (-109.73%), less than Opus Genetics, Inc. (6.07%), greater than Agenus Inc. (-23.05%), greater than Cognition Therapeutics, Inc. (-72.68%), greater than Seres Therapeutics, Inc. (-127.30%), less than Spero Therapeutics, Inc. (35.58%), greater than Acumen Pharmaceuticals, Inc. (-123.07%), less than Tevogen Bio Holdings Inc. (241.39%), greater than Inovio Pharmaceuticals, Inc. (-666.47%),
| Company | ROE | Market cap |
|---|---|---|
| -26.58% | $94.57M | |
| -109.73% | $18.88M | |
| 6.07% | $328.84M | |
| -23.05% | $137.42M | |
| -72.68% | $89.03M | |
| -127.30% | $55.20M | |
| 35.58% | $165.02M | |
| -123.07% | $143.56M | |
| 241.39% | $43.84M | |
| -666.47% | $58.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TuHURA Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TuHURA Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is TuHURA Biosciences, Inc.'s ROE?
How is the ROE calculated for TuHURA Biosciences, Inc. (HURA)?
What is the highest ROE for TuHURA Biosciences, Inc. (HURA)?
What is the 3-year average ROE for TuHURA Biosciences, Inc. (HURA)?
What is the 5-year average ROE for TuHURA Biosciences, Inc. (HURA)?
How does the current ROE for TuHURA Biosciences, Inc. (HURA) compare to its historical average?